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Sleep is involved in the regulation of major organ functions in the human body, and disrup-
tion of sleep potentially can elicit organ dysfunction. Obstructive sleep apnea (OSA) is the
most prevalent sleep disorder of breathing in adults and children, and its manifestations
reﬂect the interactions between intermittent hypoxia, intermittent hypercapnia, increased
intra-thoracicpressureswings,andsleepfragmentation,aselicitedbytheepisodicchanges
in upper airway resistance during sleep.The sympathetic nervous system is an important
modulator of the cardiovascular, immune, endocrine and metabolic systems, and alter-
ations in autonomic activity may lead to metabolic imbalance and organ dysfunction. Here
we review how OSA and its constitutive components can lead to perturbation of the auto-
nomic nervous system in general, and to altered regulation of catecholamines, both of
which then playing an important role in some of the mechanisms underlying OSA-induced
morbidities.
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INTRODUCTION
Obstructivesleepapnea(OSA)isthemostprevalentformof sleep
disorderedbreathing.Ithasbeenestimatedthat2–4%of theadult
population in western countries suffer from clinically signiﬁcant
OSA (Young et al., 2002), and in children the prevalence is esti-
mated to be between 1 and 3%, although considerable variation
exists, most likely reﬂecting the absence of large-scale epidemio-
logical studies with accurate phenotype assessments (Newacheck
andTaylor,1992;Guilleminaultetal.,2005;LumengandChervin,
2008). In recent years, OSA is becoming increasingly more preva-
lentastheaveragebodyweightofthepediatricpopulationisrising
(Tauman and Gozal, 2006).
Obstructive sleep apnea is characterized by repetitive collapse
or near collapse of the upper airway during sleep,and these repet-
itive events impose substantial adverse effects on multiple organ
systems in both adults and children, thereby emphasizing the
importance of improving our understanding on the underlying
pathophysiology of this disorder. As a result of these mechani-
cal changes in the airway, hypoxemia, and hypercapnia develop,
which further stimulate respiratory effort (Owens et al., 2008).
However, without airway opening the increased drive is ineffec-
tiveatincreasingventilation,suchthatgenerally,albeitnotalways,
the apnea/hypopnea typically continues until the patient arouses
from sleep and terminates the obstruction. After airway reopen-
ing,hyperventilation occurs to reverse the blood gas disturbances
that developed during the respiratory event (Eckert et al., 2009).
Therepetitivenatureof theseapneasandthearousaleventsresults
in signiﬁcant sleep fragmentation and promote excessive daytime
sleepiness (Stepanski, 2002), fatigue, neurocognitive dysfunction,
and increased cardiovascular morbidity (Kim et al., 2011).
Increasedintra-thoracicpressureswingsareanimportantcom-
ponent of OSA, and increased negative inspiratory intra-thoracic
pressures generated against the occluded pharynx increase the left
ventricular (LV) transmural pressures, and hence augment the
LV afterload. These changes also increase venous return, aug-
menting right ventricular (RV) pre-load, whereas OSA-induced
hypoxia will result in pulmonary vasoconstriction,therefore lead-
ing to increases in RV afterload. Taken together, RV distension,
impairment of LV ﬁlling, and increased sympathetic activity will
occur,andcansynergisticallyincreasemyocardialoxygendemand
in a contextual setting in which apnea-related hypoxia will reduce
tissue oxygen delivery (Kasai and Bradley, 2011). Upon arousal
from sleep, sympathetic activity, blood pressure, cardiac output,
and heart rate rapidly increase, resulting in more increased car-
diac oxygen demand at a time when arterial oxygen saturation is
at its lowest level (Eckert et al., 2009). This can precipitate more
severe myocardial ischemia and impair cardiac contractility and
diastolic relaxation. Over time, such stresses may contribute to
development or progression of cardiac remodeling, hypertrophy,
and failure, while also prescribe an array of changes that may
adversely impact the vasculature.
Based on aforementioned alterations as induced by OSA, it
becomes apparent that the autonomic nervous system (ANS)
activityislikelytoplayimportantpathophysiologicalroles.There-
fore,themajoraimof thecurrentpaperistoreviewthealterations
in ANS activity and catecholaminergic systems in the context of
sleep apnea. The ANS of mammals is involved with involuntary
movements, actions, and organ functioning. This system can be
further subdivided into the sympathetic motor system which is
involved with quick responses, and the parasympathetic motor
system which is involved with slower relaxing responses. Sympa-
theticstimulationmayresultinexcitatory,dilatory,andinhibitory
effects on vessels,muscles,and organs. Consequently,a large body
of research has been conducted to understand the autonomic
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alterations that occur with the transition from waking to sleep,
and throughout sleep state dynamics. During normal sleep there
are changes in sympathetic nerve activity (SNA) that are tightly
regulated by sleep state distribution. Indeed,SNA,blood pressure,
and heart rate are lower in normal subjects while they are in deep
non-REM (NREM) sleep than when awake, and during rapid eye
movement (REM) sleep SNA increases above the levels recorded
during wakefulness, even though blood pressure and heart rate
return to the same levels recorded during wakefulness (Hornyak
et al.,1991; Somers et al., 1993a).
In OSA patients, the repetitive respiratory events lead to inter-
mittent hypoxia (IH) and CO2 retention, both of which can
augment SNA via stimulation of central and peripheral chemore-
ceptors(Somersetal.,1989a).Carotidsinusbaroreceptorswillalso
augment SNA coincident with the time in which they are being
unloaded, because of the reduction in blood pressure and stroke
volume during obstructive apneic events. Apnea also enhances
SNA by eliminating reﬂex inhibition of SNA arising from pul-
monary stretch receptors (Somers et al.,1989b). Sleep fragmenta-
tion and arousals from sleep at apnea termination also augment
SNA and reduce cardiac vagal activity, although spontaneous
arousals per se are associated with acute increases in SNA along
with decreases in parasympathetic activity, which can precipitate
post-apneic surges in blood pressure and heart rate (Horner et al.,
1995, p. 67; Figure 1). These adverse autonomic effects induced
by OSA may persist even during waking hours (Spaak et al.,2005;
Kasai and Bradley,2011).
CATECHOLAMINE PRODUCTION AND SYMPATHETIC
ACTIVATION
Catecholamines (CAs; e.g., norepinephrine and epinephrine)
are key hormones that prepare the body for one of its most
primevalreactions:the“ﬁghtorﬂight”response.CAsincreasesthe
contractility and conduction velocity of cardiomyocytes, leading
to increased cardiac output and a rise in blood pressure. More-
over, they facilitate breathing by bronchodilation, and urge the
production of vital energy by mobilizing the body’s metabolic
reserves (lipolysis and glycogenolysis). Past concepts held that the
adrenal medulla and the postganglionic ﬁbers in the sympathetic
nervous system were the only systems responsible for the produc-
tion,storage,andreleaseof CAs.Morerecentﬁndingssuggestthat
phagocytic cells, lymphocytes (Flierl et al., 2008), and adipocytes
(Vargovicetal.,2011)canalsosynthesizeandreleaseCAs.Because
the brain and the immune system are some of the major adap-
tive systems, and communicate with each other extensively in an
attempt to regulate body homeostasis, a common “language” is
needed to facilitate this crosstalk. Key systems involved in this
crosstalk are the hypothalamic–pituitary–adrenal (HPA) axis and
the ANS, consisting of the adrenergic sympathetic nervous sys-
tem, the vagus-mediated parasympathetic nervous system, and
the enteric nervous system (Elenkov et al.,2000).
The synthesis of CAs relies on tyrosine and the activity of
two key enzymes, namely tyrosine hydroxylase (TH), which is
known to be the rate-limiting step in catecholamine synthesis,
and dopamine β-hydroxylase (DBH), which converts dopamine
to norepinephrine (Elenkov et al.,2000). The catecholamine neu-
rotransmitters are dopamine, norepinephrine, and epinephrine.
Although both norepinephrine and the methylated derivative epi-
nephrine are stored in synaptic vesicles of neurons,epinephrine is
not a neuromediator at the postganglionic sympathetic endings,
with norepinephrine constituting the principal neurotransmitter
of sympathetic postganglionic endings.
Tyrosine is transported into catecholamine-secreting neurons
and adrenal medullary cells where catecholamine synthesis takes
place. The ﬁrst step in the process requires TH with tetrahydro-
biopterin (H4B) as cofactor. The hydroxylation reaction generates
FIGURE1|S c hematic diagram underlying the sympathetic nerve system activation associated with obstructive sleep apnea syndrome that may lead
to increased cardiovascular disease risk.
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DOPA(3,4-dihydrophenylalanine).DOPAdecarboxylaseconverts
DOPA to dopamine,dopamine β-hydroxylase converts dopamine
to norepinephrine and phenylethanolamine N-methyltransferase
converts norepinephrine to epinephrine. Within the substantia
nigraandsomeotherregionsof thebrain,synthesisproceedsonly
to dopamine. Within the adrenal medulla,dopamine is converted
to norepinephrine and epinephrine (Hui et al., 2003). Once syn-
thesized, dopamine, norepinephrine, and epinephrine are pack-
aged in granulated vesicles. Within these vesicles, norepinephrine
and epinephrine are bound to ATP and chromogranin A.
The actions of norepinephrine and epinephrine are exerted via
receptor-mediatedsignaltransductionevents.Therearethreedis-
tincttypesof adrenergicreceptors:α1,α2,andβ,witheachinclud-
ing several sub-classes that exhibit different activity depending on
the receptor in the target organ. Dopamine binds to dopamin-
ergic receptors identiﬁed as D-type receptors and there are four
sub-classes identiﬁed as D1,D 2,D 4, and D5. Activation of the
dopaminergic receptors results in activation of adenylate cyclase
(D1 and D5) or inhibition of adenylate cyclase (D2 and D4). In
responsetostressstimulisuchasfear,pain,extremetemperatures,
hypoxia, or hypotension, CAs are released directly into the circu-
lation,activating peripheral adrenergic receptors with subsequent
chronotropic and inotropic effects on the heart, redistribution of
blood ﬂow to organs and muscles, and release of energy through
glycolysis and lipolysis. This systemic effect also includes sensitiz-
ing certain receptors to subsequent sympathetic or somatic nerve
stimulation,along with concomitant inhibition of pain sensation,
thus facilitating the coordinated responses that characterize the
“ﬁght or ﬂight”situation (Smith et al.,1998).
ASSESSMENT OF AUTONOMIC FUNCTION AND NORMAL
SLEEP PHYSIOLOGY
Direct measurements of autonomic activity, particularly during
sleep, are not an easy task, and require invasive approaches. Con-
sequently, the vast majority of such studies have been conducted
usinganimalmodels.However,recenttechnologicaladvanceshave
enabled direct measurements of sympathetic activity to be per-
formed for extended periods of time in human muscle. Further-
more, surrogate markers of ANS activity such as linear and non-
lineardynamicanalysesof heartratevariability(HRV),peripheral
arterial tonometry (PAT),continuous beat-to-beat blood pressure
monitoring, non-invasive radionuclide imaging, or quantitation
of serum and urine catecholamines and their metabolic products
have emerged as useful markers of changes in ANS, thereby per-
mittingmoreextensiveprobingof theautonomicsysteminhealth
and disease (Smith et al.,1998).
Sleep is involved in the regulation of peripheral organ func-
tion, such as endocrine and cardiovascular function, and speciﬁc
changes in peripheral organ systems occur during both REM and
non-REM (NREM) components of sleep in healthy individu-
als. One well established sleep-associated cardiovascular change
is the decrease in blood pressure and heart rate that occurs dur-
ing sleep in a variety of species, a phenomenon generally referred
to as “blood pressure dipping” (Antic et al., 2001). The sleep-
related decrease in blood pressure occurs in addition to the blood
pressure changes induced by the circadian clock and changes in
body posture that typically accompany sleeping behaviors. Blood
pressure dipping is contingent upon a reduction in global sym-
pathetic tone activity (reﬂecting increased parasympathetic tone
along with sympathetic withdrawal) as non-dippers exhibit an
increase in sympathetic tone at sleep onset (Ziegler, 2003). Sleep
statetransitionsarealsoaccompaniedbyotherchangesinthecar-
diovascular system, for example, when transitioning from NREM
sleeptoREMsleep,bloodpressure,andheartratetypicallyincrease
and become more unstable (Schwimmer et al., 2010). These phe-
nomena are altered in OSA patients, and are believed to underlie
the increased risk for development of hypertension, one of the
important cardiovascular morbidities of the disorder.
RODENT MODELS OF OSA AND AUTONOMIC FUNCTION
The manifestations of OSA reﬂect the interactions of IH, inter-
mittenthypercapnia,increasedintra-thoracicpressureswings,and
sleep fragmentation, as elicited by the episodic changes in upper
airway resistance during sleep. Data from clinical studies and ani-
mal models, particularly those reﬂecting exposures to IH, have
revealed the induction of sympathetic nerve stimulation leading
to vasoconstriction and hypertension, whereby both baro- and
chemoreceptorsactivityandregulationareinvolvedinthesympa-
thetic control of blood pressure (Guyenet, 2006). The baroreﬂex
providesanegativefeedbackloopinwhichelevatedbloodpressure
inhibits sympathetic outﬂow, decreases heart rate, and, thus, low-
ers blood pressure. In a similar fashion, decreased blood pressure
activates baroreﬂex mechanisms,causing heart rate increases,and
blood pressure to rise (Golbidi et al., 2011). Attenuated barore-
ceptor sensitivity is proposed to lead to increased sympathetic
a c t i v a t i o n .I nar e c e n tr e v i e w ,Prabhakar and Kumar (2010) con-
cludedthatpatientswithOSAdoexhibitareductioninbaroreﬂex
sensitivity,asevidencedbyattenuatedheartrateandvascularresis-
tance responses to baroreceptor activation,and that restoration of
baroreﬂex sensitivity will occur after treatment with CPAP (Carl-
son et al., 1993; Bonsignore et al., 2006; Monahan et al., 2006;
Cooper et al., 2007). Similarly, when rodents were exposed to IH,
attenuated baroreﬂex function,sensitivity and activity,or changes
in the reﬂex set point depending on the severity of the hypoxia
stimulusdevelopedovertime(Brooksetal.,1999;Greenbergetal.,
1999; Lai et al., 2006; Gu et al., 2007; Peng et al., 2012). These
changes also led to exaggerated sympathetic activity and eventu-
allyelicitedelevationsof bloodpressureandtheeliminationof the
normal blood pressure dipping during sleep.
On the other hand, the arterial chemoreceptors, especially the
carotid bodies which operate as the primary sensors for hypoxia
and the ensuing carotid chemoreﬂex will activate SNA, elevate
blood pressure, and stimulate breathing (Prabhakar and Kumar,
2010). Since the introduction of a rodent IH model by Fletcher
etal.(1992),augmentedchemoreﬂex-stimulatedsympatheticout-
ﬂow was clearly identiﬁed (Bao et al., 1997), and found to be
mediatedviatherenin–angiotensinsystemandalsoviathemodu-
lationofoxygen-sensingincarotidbodiesbyactivationofHypoxia
Inducible Factor-1 (HIF-1) and down regulation of HIF-2,as well
as via changes in oxidative stress activity (La Rovere et al., 1998;
Fletcher et al.,2002; Peng et al.,2003; Prabhakar et al.,2009). Fur-
thermore, stimulation of carotid bodies by IH is also associated
with a reduction in baroreﬂex sensitivity in cats (Rey et al.,2004),
rats(Soukhova-O’Hareetal.,2006a;Guetal.,2007;Linetal.,2008;
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Yan et al.,2008,2009),and mice (Lin et al.,2007). These effects of
chronic IH on carotid body function and sensitivity are reversed
completely after re-exposure to normoxia in adult subjects (Peng
et al.,2003),but not if IH exposures occur during a critical period
of postnatal development (Soukhova-O’Hare et al.,2006b,2008).
The reversible nature of the carotid body responses to chronic
IH in adults could explain why CPAP therapy reverses some of
theadversecardio-sympatheticeffectsinOSApatients(Prabhakar
and Kumar, 2010). Exposure of mice to more than 30days of IH
elicitedelevatedsystemicbloodpressurethatpersistedevenduring
normoxia,alongwithenhancedsympathoadrenalactivityasmea-
sured by catecholamine levels,especially norepinephrine. Surgical
denervation of peripheral chemoreceptors or adrenal demedu-
lation and chemical denervation of the peripheral sympathetic
nervous system prevented the increase in arterial blood pressure
(Lesske et al.,1997; Dematteis et al.,2008; Gonzalez-Martin et al.,
2009). A more recent study by Gonzalez-Martin et al., 2011),
who exposed rats to 15days of IH, concluded that IH leads to
a bias in the integration of the inputs arising from the carotid
body characterized by a diminished drive of ventilation along
with an exaggerated activation of brainstem sympathetic neu-
rons. In conclusion, chronic IH selectively augments the carotid
body sensitivity to hypoxia resulting in a long lasting activation
of chemosensory inputs to the medial and commissural nuclei
of the solitary tract (Prabhakar et al., 2001; Kara et al., 2003).
In parallel, extensive changes occur in central neural regions
governing autonomic system nervous system outﬂow and other
integrated outputs such as respiration (Ai et al., 2009). These
changes notwithstanding, a multiplicity of interactions and addi-
tionalmechanismsarelikelyinvolvedandaredependentontheage
at which IH occurs, the severity, cycle duration, and overall dura-
tion of IH,and the association of additional perturbations such as
hypercapnia or hypocapnia (Waters and Gozal,2003;Reeves et al.,
2006; Mahamed and Mitchell, 2008; Iturriaga et al., 2009; Zoccal
et al., 2009; Kline, 2010; Xing and Pilowsky, 2010; Baker-Herman
and Strey, 2011; Dodig et al., 2011; Molkov et al., 2011; Prabha
et al.,2011).
A characteristic feature of mammalian sleep is decreased pos-
tural muscle tone, especially during REM sleep. The suppression
of motor activity also involves respiratory muscles, particularly
in those that combine postural and respiratory functions, such as
the intercostal and pharyngeal muscles; this effect of REM sleep is
modulated by catecholamine secretion. The genioglossus muscle,
animportantupperairwaydilatorisinnervatedbythehypoglossal
motoneuron,andbothnorepinephrineandserotoninleadtoexci-
tation of orofacial motoneurons, including those that innervate
upper airway muscles, and both noradrenergic (NE) and sero-
tonergic brainstem neurons have been shown in animal models
to reduce their activity during slow-wave sleep and stop ﬁring
during REM sleep (Aston-Jones and Bloom, 1981; Kubin et al.,
1998; Fenik et al., 2005; Rukhadze and Kubin, 2007). These data
suggest that sleep-related withdrawal of aminergic excitation may
cause decrements of motoneuronal activity, thereby contributing
tosleep-relatedupperairwayhypotonia.Chanandcolleagueshave
conﬁrmed this hypothesis in rats, and identiﬁed an endogenous
noradrenergic drive that contributes to the genioglossus muscle
activity. Furthermore, withdrawal of the excitation is mediated
by alpha1-adrenergic receptors, which play a major role of sleep-
relatedsuppressionof activityinhypoglossalmotoneurons(Chan
et al.,2006).
Recurrent arousals in the context of OSA lead to sleep frag-
mentation and are associated with state-related increases in the
sympathetic activity to peripheral arteries, that in turn may lead
to large repetitive blood pressure rises that can be as high as 60–
80mmHg. These oscillations in blood pressure are thought to be
important risk factors in the development of vascular events (Bao
etal.,1999;KohlerandStradling,2010).Horneretal.(1995)stud-
ied tracheostomized dogs and showed that arousals from sleep are
associated with marked increases in heart rate that can be atten-
uated by sympathetic blockade. Evidence for alterations in the
sympatheticactivitythataccompaniessleepfragmentationinclude
increasedlevelsofcortisol,epinephrine,andnorepinephrinealong
with increased heart rate and systolic blood pressure (Andersen
et al., 2004, 2005; Everson and Crowley, 2004; Perry et al., 2007;
Tartar et al.,2009).
AUTONOMIC ALTERATIONS IN ADULT PATIENTS WITH OSA
In combination with other co-factors, sympathetic and cate-
cholaminergic alterations are believed to play an important role
in the pathophysiology of the cardiovascular morbidity in adults
with OSA (see Table 1 for summary). The cumulative evidence
that has emerged in the last three decades using multiple meth-
ods to quantify sympathetic activity in patients with OSA sup-
ports this putative association. Indeed,OSA patients demonstrate
a reduction in vagal modulation of HRV in comparison with
controls (Aydin et al., 2004; Kesek et al., 2009; Bianchi et al.,
2010; Balachandran et al., 2012), and such alterations in car-
diac sympathetic and parasympathetic modulation are improved
after treatment with either CPAP or upper airway surgery (Cheng
et al., 2011; Choi et al., 2011; Gapelyuk et al., 2011). However,
we should acknowledge that although HRV measurements pro-
videnon-invasiveprobesintoANSfunction,theyarefraughtwith
substantial limitations (Poupard et al.,2011),such that alternative
methodshavebeenused.However,discussionof theprosandcons
of such methodologies is clearly beyond the scope of this review.
Hypertension is one of the leading cardiovascular morbidities
of OSA, and enhanced sympathetic activity is believed to play a
fundamental role in the blood pressure elevation. Thus, beat-to-
beatmonitoringof bloodpressurechangeshasbeenusedtoassess
changes in sympathetic activity in OSA patients. In general, OSA
patientsalllevelsof severitydemonstrateincreasesinbothsystolic
anddiastolicbloodpressureduringsleepandwakefulness(Table1;
Kohler et al.,2008). Furthermore,high blood pressure in the con-
text of OSA was resistant to conventional anti-hypertensive drug
therapy (Pedrosa et al., 2011), with in some instances resembling
pheochromocytoma, with catecholamine surges and malignant
hypertension becoming manifest (Cheezum and Lettieri, 2010).
Although a large group of studies have demonstrated that blood
pressure elevations were attenuated by treatment of OSA (Weiss
et al., 2007; Friedman and Logan, 2009; Table 1), the changes in
blood pressure have traditionally been modest (Duran-Cantolla
et al., 2010), even if the strength of the association may apply
onlytoselectedsubsetsofthegeneralpopulation(Cano-Pumarega
et al., 2011). Indeed, there are reported differences regarding the
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Table 1 | Summary of autonomic nervous system alterations in adult OSA patients.
Modality Reference Effect
Blood pressure Bixler et al. (2000), Suzuki et al. (1996), Borgel et al. (2004), Heitmann
et al. (2004), Dhillon et al. (2005), Pepperell et al. (2002), Faccenda et al.
(2001), Dernaika et al. (2009), Robinson et al. (2008), Patruno et al.
(2007), Wilcox et al. (1993), Hui et al. (2006), Duran-Cantolla et al. (2010),
Marrone et al. (2011)
OSA is associated with elevated blood pressure that
is attenuated by CPAP therapy; differences emerge
regarding the level of reduction in BP after treat-
ment, the circadian time at which reduction occurs
(sleep/wakefulness), and whether the systolic or
diastolic component is more affected
Urine and blood
catecholamine levels
Fletcher et al. (1987), Baruzzi et al. (1991), Ziegler et al. (1997),
Minemura et al. (1998), Loredo et al. (1999), Elmasry et al. (2002),
Sukegawa et al. (2005), Drager et al. (2007), Kohler et al. (2008),
Comondore et al. (2009), Zhang et al. (2011), Bao et al. (2002), Ziegler
et al. (2001), Kohler et al. (2011)
OSA patients demonstrate sustained elevation in
catecholamine levels that are attenuated by treat-
ment, and are elevated again by treatment with-
drawal. Hypertensive patients will experience a
larger reduction in catecholamine levels
Muscle synaptic nerve
activity (MSNA)
Imadojemu et al. (2007), Usui et al. (2005), Narkiewicz et al. (1999a),
Gilmartin et al. (2008, 2010), Xie et al. (1999), Morgan et al. (1996)
Higher basal MSNA in OSA patients, which is atten-
uated with treatment
Heart rate variability
(HRV)
Balachandran et al. (2012), Bianchi et al. (2010), Aydin et al. (2004), Kesek
et al. (2009), Choi et al. (2011), Cheng et al. (2011), Gapelyuk et al. (2011)
Reduced HRV is found in OSA patients, and is
improvedaftertreatmentwithCPAPorupperairway
surgery
reduction in systolic and diastolic components of blood pressure,
withonlydaytimediastolicbloodpressurebeingaffectedbytreat-
ment in some studies, and with both systolic and diastolic values
beingfavorablyreducedduringsleepinotherstudies(Voogeletal.,
1999; Norman et al., 2006; Marrone et al., 2011), or during day-
time(Wilcoxetal.,1993;Ipetal.,2004).Furthermore,onlysystolic
bloodpressurewasreducedduringthenightaftertreatmentinyet
otherstudies(Suzukietal.,1993).Thesedifferencesintheresponse
totherapycanbeattributedtoalargenumberofconfounderssuch
as ethnicity, gender, age, presence of underlying diseases, as well
as genetic polymorphisms. It is possible that the more favorable
reduction in diastolic blood pressure reﬂects its dependency on
arteriolar tone,which is highly inﬂuenced by sympathetic activity,
thelatterbeinghighinpatientswithOSAbothduringwakefulness
and during sleep (Marrone et al., 2011).
Because of the unique roles that catecholamines play in
the transduction of sympathetic activity, multiple studies have
assessed their concentrations, and shown the presence of ele-
vated levels of catecholamines in both urine and plasma among
patients with OSA. Some of these studies also showed that cate-
cholamine levels were attenuated after treatment, thereby lead-
ing to the proposition that catecholamines levels may serve
as a surrogate biomarker for OSA (Fletcher et al., 1987; Baruzzi
et al., 1991; Ziegler et al., 1997; Minemura et al., 1998; Loredo
etal.,1999;Elmasryetal.,2002;Sukegawaetal.,2005;Drageretal.,
2007; Kohler et al., 2008; Comondore et al., 2009; Zhang et al.,
2011). However, data emerging from clinical trials has revealed
substantialvariabilityregardingCPAPtreatmentanditseffectson
catecholamineslevels,withsomereportingareductionincirculat-
ing catecholamines that extended into daytime and wakefulness,
while others did not ﬁnd any effect of CPAP treatment on cat-
echolamine concentrations (Ziegler et al., 2001; Bao et al., 2002;
Comondore et al., 2009). These discrepancies are probably and
partially explained by the fact that the therapeutic effect of CPAP
on blood pressure and sympathetic outﬂow is more prominent
in hypertensive patients when compared to normotensive OSA
patients (Heitmann et al., 2004). Mills et al. (2006) assessed the
effect of CPAP therapy on norepinephrine kinetics, and found
that CPAP treatment in OSA patients leads to a reduction in renal
sympathetic neural activity by enhancing the renal clearance of
norepinephrine rather than by attenuating norepinephrine syn-
thesis rates.Another important observation was recently reported
by Kohler and coworkers who studied the effect of CPAP with-
drawal in patients with OSA. These investigators showed that
CPAP withdrawal was not only accompanied by rapid recur-
rence of OSA symptoms,return of subjective sleepiness,impaired
endothelial function, and increases in blood pressure and heart
rate,butalsobyelevationinurinarycatecholamines(Kohleretal.,
2011). Altogether, these studies seem to support the assumption
that OSA patients sustain elevations in catecholamine levels that
are attenuated by treatment, and are elevated again by treatment
withdrawal. These observations would make it plausible to con-
sider catecholamine levels in the blood or urine as a potentially
viable biomarker of OSA severity that can be used to monitor
patients responses to treatment (Comondore et al., 2009; Tasali
et al., 2011). However, the role of catecholamine levels as a valid
biomarker for diagnosis of OSA is not ﬁrmly established, most
likely because of the large amount of confounding factors and
associated morbidities that frequently accompany OSA and can
independently lead to changes in catecholamine levels. Indeed,
confounding factors such as age, hypertension, obesity, and the
use of anti-hypertensive medications are not easy to control for,
thereby increasing the difﬁculty to interpret at the individual
patient level the real impact of OSA on catecholamine levels.
In addition to clinical trials aiming to deﬁne the contribution
of each component of OSA to sympathetic activity, Foster et al.
(2009) conducted an experimental randomized controlled study
in humans in which they exposed 10 healthy men to 6h/day of IH
or sham (2min cycles). After 4days of IH, mean systemic blood
pressure increased by 4mmHg, and nitric oxide derivatives were
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reduced by 55%, the latter being associated with an increase in
thepressorresponseandincerebralvascularresistancetohypoxia
(Foster et al., 2009). This study clearly supports previous ﬁnd-
ings demonstrating that hypoxemia elevates sympathetic nervous
system tone and exaggerates sympathetic basal activity in patients
withOSA(Leuenbergeretal.,1995;Somersetal.,1995;Smithetal.,
1996; Imadojemu et al., 2007). Gilmartin et al. (2008) measured
changes in muscle sympathetic nerve activity (MSNA) in subjects
exposedtochronicsustainednocturnalhypoxiaandfoundanaug-
mentedMSNAandariseinbloodpressureafter14nightsof expo-
sure. Recently, the same group (Gilmartin et al., 2010) conﬁrmed
these results in healthy subjects exposed to intermittent nocturnal
hypoxia (9h/night) for 28days. These investigators found aug-
mented MSNA with elevation of blood pressure after 2weeks
of exposure, which further increase after 4weeks of IH. Using
anotheraspectofMSNAmeasurementscombinedwithelectrocar-
diogram recordings and consisting of assessments of sympathetic
burstlatencyinhumans,severalinvestigators(Morganetal.,1996;
Xie et al., 1999) have shown that arousal from sleep, regardless
of whether it occurs spontaneously or is evoked by an apnea,
consistently elicits reductions in sympathetic burst latency. These
observations may reﬂect a temporary diminution of the barore-
ﬂex buffering of sympathetic outﬂow,and may play an important
roleinthecardiovascularmorbidityinducedbyrepetitivearousals
fromsleep.DatafromstudiescomparingOSApatientstocontrols
show a higher basal MSNA level in OSA patients, and also exag-
gerated MSNA responses to hypoxia, with treatment with CPAP
attenuatingbothbasalMSNAandhypoxicMSNAresponses.Thus,
arterial chemoreﬂex sensitivity is increased in OSA and can be
reversed by treatment (Narkiewicz et al., 1999b; Usui et al., 2005;
Imadojemu et al., 2007).
As mentioned above,repetitive arousals are not only an impor-
tant component of OSA,but are also associated with state-related
increasesinthesympatheticactivitytoperipheralarteries(Loredo
et al., 1999), which will usually lead to large repetitive blood
pressure rises as high as 60–80mmHg (Somers et al., 1989a).
In an experimental study of nine healthy humans, intra-thoracic
pressure changes induced by the Mueller maneuver were asso-
ciated with oscillations in blood pressure and increased SNA.
This is somewhat different from the time sequence of changes
in obstructive apnea, whereby SNA is initially increased, and the
bloodpressureelevationusuallyoccurslaterattheendoftheapnea
(Somers et al., 1993b). Experimental paradigms of sleep disrup-
tion have demonstrated that sleep perturbations alone may play
animportantroleintheautonomicchangesleadingtothecardio-
vascularmorbidityobservedinOSA.Leiteretal.(1985)studied11
men and showed that a single night of sleep deprivation decreases
upperairwaydilatormuscleactivityduringhypercapnicrebreath-
ing, a response that may predispose to upper airway collapse. In
fact, loss of sleep is associated with reduced ventilatory responses
tohypercapniaandhypoxia,aresponsethatpotentiallycandeteri-
orate respiratory performance to airway obstruction (White et al.,
1983). It is possible that such changes in upper airway dynam-
ics may reﬂect altered ANS outputs to upper airway as discussed
above.
Insummary,increasesinsympatheticactivityduringsleepmay
beexplainedbytherepetitiveapneiceventsandtheirintegralcon-
stitutive elements. Remarkably, high sympathetic drive is present
even during daytime wakefulness, at a time that no respiratory
disturbances occur,and when both arterial oxygen saturation and
carbon dioxide levels are normal (Narkiewicz and Somers, 2003).
AUTONOMIC ALTERATIONS IN CHILDREN WITH OSA
For many years, the prevailing assumption was that children were
somewhatprotectedfromanycardiovascularmorbiditywithpedi-
atric OSA due to the redundancy of protective mechanisms, and
the increased vascular capacitance and reserve in children (see
Table 2 for summary). However,such assumptions have been dis-
proveninthelast15yearssincethepublicationof initialpapersby
Aljadeff etal.(1997)showingalteredANSfunctionandbyMarcus
et al. (1998) showing that elevations in blood pressure did occur
in children with relatively severe OSA.
Themechanismsunderlyingcardiovascularmorbiditiesinchil-
dren most probably closely overlap the mechanisms leading to
suchmorbidityinadults.Inaseriesof studiesoverthelastdecade,
our laboratory has shown that the combination of IH, sleep frag-
mentation, episodic hypercapnia, and increased intra-thoracic
pressure swings, can separately and in conjunction activate or
amplify the onset and propagation of endothelial dysfunction,
atherogenesis, increased systemic inﬂammation, oxidative stress,
andactivationof adhesionmoleculesandcoagulation(Parishand
Somers, 2004; Gozal et al., 2007; Gozal and Kheirandish-Gozal,
Table 2 | Summary of autonomic nervous system alterations in children with OSA.
Modality Reference Effect
Blood pressure
monitoring
Marcus et al. (1998), O’Driscoll et al. (2009a,b), Kohyama et al.
(2003), Leung et al. (2006), Bixler et al. (2008), Amin et al. (2004)
Arterial blood pressure was increased in OSA children
and more pronounced during NREM sleep and during
arousals
Urine and blood
catecholamines
Snow et al. (2010), Kaditis et al. (2009), Oliveira et al. (2010), Kelly
et al. (2010), O’Driscoll et al. (2011), Nakra et al. (2008)
OSA patients exhibit severity-dependent elevations in
catecholamine levels which respond to treatment
Heart rate variability
(HRV)
Aljadeff et al. (1997), Baharav et al. (1999), Constantin et al. (2008),
Muzumdar et al. (2011)
OSA alters cardiac beat-to-beat variation that is most
prominent during slow heart rates. Improvements in
HRV occur after treatment
Peripheral arterial
tonometry (PAT), pulse
transit time (PTT)
O’Brien and Gozal (2005, 2007),Tauman et al. (2004), Katz et al.
(2003), Pillar et al. (2002), Brietzke et al. (2007), Foo et al. (2006),
Pepin et al. (2005), Paruthi and Chervin (2010)
Exaggerated sympathetic responses following vital
capacity sighs and ice-cold hand pressor tests. Unique
PTT signatures appear to be present in pediatric OSA
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2008; Kim et al., 2011) in parallel with the important process of
sustained activation of the sympathetic nervous system (Somers
et al., 1995). Furthermore, we have provided initial evidence that
the alterations in ANS function may be reﬂected by the presence
of either increased sympathetic nervous system tone, increased
responsiveness,ortheemergenceofsympathetic–parasympathetic
imbalance (Bhattacharjee et al.,2009).
Studiesexploringalterationsinautonomicfunctioninchildren
with sleep disordered breathing are relatively sparse, particularly
because of the difﬁculties associated with invasive assessments
such as nerve recordings (Narkiewicz and Somers, 2003). There-
fore,all studies have resorted to non-invasive probing of theANS.
Aljadeff et al. (1997) used HRV analyses including both linear
and non-linear dynamic analyses and Poincare scatter plots, and
showed the presence of substantial alterations in sympathetic
tone in children with OSAS. Similar ﬁndings were subsequently
reportedusingpowerspectralanalysisof heartrate(Baharavetal.,
1999), whereby a sympathetic predominance during REM sleep
emerged in pediatric OSA patients. O’Brien and Gozal (2005)
measured sympathetic responses during wakefulness in 28 chil-
dren with sleep disordered breathing and in 29 healthy controls
using PAT, and demonstrated exaggerated sympathetic responses
following vital capacity sighs and ice-cold hand pressor tests in
the OSA group, thereby providing compelling evidence on the
presence of increased sympathetic reactivity during wakefulness
in children with OSA. Other studies using heart rate dynam-
ics have also suggested that sleep state and OSA are important
determinants of cardiac autonomic outﬂow that can be readily
assessed with these methods and potentially provide a diagnostic
algorithm (Shouldice et al., 2004; Deng et al., 2006). A reduc-
tion of the increased HR variability during sleep after treatment
was initially reported with adenotonsillectomy in OSA children
(Constantin et al., 2008), and subsequently conﬁrmed (Muzum-
dar et al.,2011).In another study that included 25 children (mean
age 10.2±2.3years) undergoing a diagnostic assessment for OSA,
and 25 age-matched healthy control subjects, all participants
underwent an overnight polysomnography and were subjected to
autonomic cardiovascular tests for the assessment of autonomic
function (head-up tilt test, Valsalva maneuver, and deep breath-
ing test). Increased basal sympathetic activity during wakefulness
and also impaired severity-dependent responses to the autonomic
challenges emerged (Montesano et al., 2010). Of note, periodic
arousals even when induced by non-respiratory events can also
triggeralterationsinautonomicfunctioninchildren(Walteretal.,
2009).
Another frequently used non-invasive tool for assessment of
changes in ANS tone is the measurement of pulse transit time
(PTT). Indeed, PTT may serve as yet another indicator of sym-
pathetic burst activity by measuring the delay from the initial LV
electrical depolarization in the electrocardiogram to the appear-
ance of the corresponding plethysmographic signal of the oxime-
try waveform at the wrist (Foo and Lim, 2006). In studies con-
ducted in healthy children in whom recordings of PAT and PTT
were simultaneously performed, it became apparent that arousals
were associated with predictable changes in both PAT and PTT,
thereby linking sympathetic discharges to non-invasive measures
in children (Pillar et al., 2002; Katz et al., 2003; Tauman et al.,
2004; O’Brien and Gozal, 2007). These ﬁndings further suggested
PTT as a potentially valuable diagnostic screening tool for OSA
and as a probe of sympathetic activity changes (Pepin et al.,
2005; Foo et al., 2006; Brietzke et al., 2007; Paruthi and Chervin,
2010).
In an effort to obtain more accurate correlates of sympathetic
activationinchildren,measurementsof theconcentrationsof cat-
echolaminesinplasmaorurinespecimenshavealsobeenexplored
in pediatric OSA patients. Kaditis et al. (2009) measured uri-
nary catecholamines in 44 OSA children with different levels of
nocturnalhypoxemia,andalsoincluded10controlchildren.Nora-
drenaline and adrenaline urine levels correlated signiﬁcantly with
the obstructive apnea–hypopnea index. Since concentrations of
catecholamines were measured in morning urine specimens col-
lectedafterarousalfromsleep,thesigniﬁcantassociationsbetween
urinarycatecholaminesandpolysomnographicindicesmostlikely
reﬂect increased nocturnal activity of sympathetic neurons and
possibly of the adrenal medulla (Kaditis et al., 2009). In a larger
cohort, Snow et al. (2010) assessed 159 habitually snoring chil-
dren who underwent overnight polysomnography and collection
oftheﬁrstmorningvoidedurinesampletomeasuretheconcentra-
tions of norepinephrine, epinephrine, and dopamine. In a subset
of children, blood samples were also drawn for gene expression
of catecholamine-relevant genes. Children with OSA had sig-
niﬁcantly higher urinary norepinephrine and epinephrine levels,
but not dopamine, compared to habitual snorers (norepineph-
rine: 40.1±24.7ng/mg creatinine vs. 31.6±16.2ng/mg creati-
nine,P <0.01;epinephrine:6.4±10.5ng/mg vs. 4.5±0.5ng/mg,
P <0.01). As previously shown by Kaditis et al. (2009), norepi-
nephrineandepinephrinelevelsweresigniﬁcantlycorrelatedwith
polysomnographic indices, but there was no evidence that body
mass index contributed to this association (Snow et al., 2010).
Thus,alteredsympatheticactivityinOSApatientsappearstooccur
independently of the presence of obesity. In addition, Snow et al.
(2010)alsoshowedahighergeneexpressionamonggenesthatare
involved in the synthesis and transport of catecholamines, as well
as in selected important receptors, with such ﬁndings suggest-
ing the presence of increased bioavailability of catecholamines.
Morerecently,severalgroupshaveconﬁrmedthatAHIisasigniﬁ-
cantindependentpredictorof noradrenalineandadrenalinelevels
(Kelly et al., 2010; Oliveira et al., 2010; O’Driscoll et al., 2011). In
a different study, Nakra et al. (2008) assessed a small group of
obese children and adolescents in whom norepinephrine levels
were assessed hourly throughout the night before and after treat-
mentwithCPAPfor3months.Catecholaminelevelswerereduced
aftertreatmentinthiscohort,furtherconﬁrmingtheeffectof OSA
on sympathetic outﬂow.
Alterations in blood pressure are one of the important mor-
bidities linked to modiﬁcations in autonomic and sympathetic
function in OSA. As mentioned above, Marcus et al. (1998) were
the ﬁrst to report alterations in systemic blood pressure in chil-
dren. The potential reduction in baroreﬂex function that have
been clearly identiﬁed in animal models have also been reported
in children with OSA (McConnell et al., 2009). Accordingly, it is
notsurprisingthatanumberof investigativegroupshaveexplored
and reported the presence of systemic blood pressure alterations
associated with OSA in pediatric population, with such changes
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being more pronounced during NREM sleep and also associated
witharousals(Kohyamaetal.,2003;Aminetal.,2004;Leungetal.,
2006; Bixler et al., 2008; O’Driscoll et al., 2009a,b). Furthermore,
severity-dependentalterationsinLVfunctionwithdecreaseddias-
tolic and systolic contractility have also been clearly identiﬁed in
pediatric OSA (Amin et al., 2008; Ugur et al., 2008; Kaditis et al.,
2010).
In the past decades, the prevalence of obesity and diabetes
has greatly increased in industrialized countries, and both sleep
curtailment and SDB are becoming recognized as contributing
factors, alongside increased caloric intake, and decreased physical
activity. The autonomic nerve system is an important regulator
of metabolic function in major organs including the liver,adipose
tissue, muscle, and pancreas, whereby alterations in autonomic
function contribute to metabolic dysfunction and obesity (Enri-
ori et al., 2011; Lambert et al., 2011; Straznicky et al., 2011).
Since as discussed earlier, sleep disorders are strongly connected
to autonomic dysfunction, the connection between sleep dis-
turbances, autonomic alterations, and metabolic morbidities is
becoming increasingly apparent (Spiegel et al., 2004; Trombetta
et al.,2010).
SUMMARY
Considering the close relationships between sleep regulatory
mechanisms and autonomic nerve system function described
heretofore, any sleep disturbance can theoretically lead to alter-
ations in sympathetic activity, and may thus elicit metabolic
and cardiovascular morbidities. Conclusive evidence has become
available to indicate that OSA components lead to pathological
activation of the sympathetic nervous system and contribute to
thepathophysiologyofhighbloodpressure,arrhythmias,andcon-
gestive heart failure in adults. In children, there is increasing data
indicating that OSA can lead to changes in heart rate responses
and elevated blood pressure. Importantly, OSA treatment using
CPAP or upper airway surgical procedures will lead to attenua-
tion of the heightened sympathetic activity, which in turn will
lower blood pressure levels and reduce cardiovascular morbidities
in adults and children. Thus, the importance of autonomic per-
turbations in the context of sleep disorders becomes apparent and
can promote metabolic, cardiovascular, and psychological mor-
bidities throughout life. Data from rodent studies further show
that there are long-term implications to the autonomic nerve
system perturbations that occur during developmental windows
in infancy and childhood in response to OSA, particularly in
the context of underlying genetic predisposing factors that gov-
ern cardiovascular and metabolic disease susceptibility (Vallee
et al., 1996; Young, 2002; Van den Hove et al., 2006; Mastorci
et al., 2009). In the clinical context, utilization of catecholamine
levels as a potential biomarker for OSA in the context of diag-
nosis and adherence to therapy is intriguing and merits further
validation.
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